RI offers partnership on vaccine development

Admin | Selasa, 30 Oktober 2012

Indonesia is offering a partneship on vaccine research and development with vaccine manufacturers in developing and Islamic countries, said an executive. President director of the stateowned vaccine producer, Bio Farma, said the company was ready to work with other companies. We hope that Bio Farma, as the only vaccine manufacturer in Indonesia, can become a center for vaccine research, development and serve as a partner to research new vaccines for developing countries, Iskandar told journalists in Bali on Sunday. Iskandar made the statement related to his readiness to host the meeting of the 13th Developing Countries Vaccine Manufacturers Network (DCVMN) to be held in Kuta from Oct. 31 through Nov. 2. According to Iskandar, all vaccine producers across the world have the same objectives, to increase the availability and quality of vaccines in order to achieve healthy communities. He explained that the aim of the DCVMN meeting was to jointly combat the spread of infectious diseases that are endemic in many developing countries. The partnership is aimed at increasing the capacity and quality of vaccines and improving vaccine research and development. Iskandar said regular meetings of vaccine manufacturers in developing countries would be needed to encourage the production and distribution of highquality vaccines selectively in the long term to meet the targets of the national immunization program for these countries. At the upcoming 13th DCVMN meeting in Bali, the Bill and Melinda Gates Foundation is also scheduled to attend as a participant, represented by Dr. Kim Bush. More than 100 international vaccine researchers and experts have confirmed attendance at the conference. The DCVMN member countries are Argentina, Bangladesh, Brazil, Cuba, Egypt, India, Indonesia, Iran, Mexico, the Republic of China, Republic of Korea, South Africa, Thailand and Vietnam. DCVMN member companies and organizations are Beijing Minhai Biotechnology Bharat Biotech International Limited, Biological E. Limited, BioManguinhos ÔÇö Institute of Technology on Immunobiologicals, BioNetAsia Co, Ltd, Cadila Pharmaceuticals Limited, Center for Genetic Engineering and Biotechnology Chengda Liaoning, China National Biotec Group (CNBG). Other members include EuBiologics, Finlay Institute, Haffkine, Hualan Bio, Incepta Ltd, Indian Immunologicals Limited, Institute of Vaccines and Medical Biologicals, Instituto Butantan, National Administration of Laboratories and Institute of Health ANLIS Dr. Carlos G. Malbran. Also Panacea Biotec Ltd, Pasteur Institute of Iran, Bio Farma, Queen Saovabha Memorial Institute, Razi Vaccine & Serum Research Institute, Serum Institute of India Ltd, Sinergium, Sinovac Biotech Ltd, SK Chemicals. sumber : http://www.thejakartapost.com/balidaily/20121029/riofferspartnershipvaccinedevelopment.html

Tagged :